The NIH Office of Technology Transfer evaluates, protects, markets, licenses, monitors, and manages the wide range of NIH and FDA discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation. To accomplish its mission, OTT oversees patent prosecution and negotiates and monitors licensing agreements. OTT performs similar functions for patenting and licensing activities for the Food and Drug Administration (FDA), another component of the Department of Health and Human Services (HHS). Other major functions within OTT include the development of technology transfer policies for NIH and with the other two major research components of HHS (FDA and the Centers for Disease Control and Prevention [CDC]) and the implementation of decisions by the Technology Transfer Policy Board.
Location: United States
Main Industry: Technology Transfer
NIH and its Role in Technology Transfer It is impossible to overstate the untapped potential that technology transfer represents. To understand why, consider the many steps involved in medical breakthroughs. Today, most important developments in medical science typically begin in laboratories, such as the discovery of specific new biological molecules, processes, or pathways, or innovative applications of existing knowledge. In most cases, these discoveries in and of themselves have limited effect beyond meeting a fairly narrow research goal. Their real impact for public health generally comes after several more significant steps - including further R&D, testing, approval by appropriate regulatory bodies (such as the FDA), manufacturing, and distribution. OTT carries out its technology transfer mandate by retaining title to inventions developed in NIH#s intramural laboratories and licensing these inventions to private entities to ensure use, commercialization, and public availability. In a similar way, extramural recipients of NIH funds, such as universities, are allowed to seek patent protection for inventions arising from their NIH-funded basic research and license the rights to private entities to promote commercialization. Over the last 20 years, NIH has executed thousands of license agreements. These licenses transfer NIH and FDA inventions to the private sector for further research and development and potential commercialization that can lead to significant public health benefits. At OTT, we#re always open to ways to make technology transfer a more user-friendly process. We are committed to seeing that the public has ongoing access to newer and more effective health care products and procedures.